Zhang, L., Yin, Z. Y., Zhang, M., Xu, H., Zhu, J., Zhao, J., Zhao, W., Jia, Y., Zhao, D., Yang, Y., Wang, S., Wang, J., Qian, X., Guo, X., Lu, H., Gu, L. (2026). Early results of neoadjuvant therapy with pyrotinib, subcutaneous trastuzumab, and capecitabine for HER2-positive early breast cancer from a prospective, single-arm, multicenter trial.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.606